Heparin Market Type, Applications, Region and Forecast Period 2022-2028

The global "heparin market" size is expected to reach USD 11.43 billion by 2027, exhibiting a CAGR of 3.9% during the forecast period. The increasing cases of cardiovascular diseases such as deep vein thrombosis & pulmonary embolism are expected to spur demand for heparin in the forthcoming years, states Fortune Business Insights, in a report, titled "Heparin Market Size, Share & Industry Analysis, By Product Type (Unfractionated Heparin (UFH), and Low Molecular Weight Heparin (LMWH)), By Source (Bovine, and Porcine), By Application (Deep Vein Thrombosis & Pulmonary Embolism, Atrial Fibrillation, Heart Attacks, Stroke, and Others), By Route of Administration (Intravenous Infusion, and Subcutaneous Injection), By End User (Hospitals & ASCs, Clinics, and Others), and Regional Forecast, 2020-2027." The market size stood at USD 8.39 billion in 2019.

The emergence of coronavirus has caused the world's economy to tumble down. We understand that this health emergency has negatively impacted various sectors across the globe. Rising support from governments and several companies can help in the fight against this highly infectious virus. There are some industries that are struggling and some are thriving. More or less, nearly every sector is estimated to be impacted by this pandemic.

We are perpetually working on our reports to help uplift businesses in this crucial time. Our expertise and experience can offer enormous benefits to help regain during this global pandemic. 

Get Request a Sample Copy of the Heparin Report:

https://www.fortunebusinessinsights.com/enquiry/sample/heparin-market-104447

Major Heparin Market Key players covered in the report include:

Opocrin S.p.A. (Formigine, Italy)
Baxter (Deerfield, U.S.)
Pfizer Inc. (New York, U.S.)
Bioiberica S.A.U. (Barcelona, Spain)
Fresenius SE & Co. KGaA (Bad Homburg, Germany)
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (Shijiazhuang, China)
Braun Melsungen AG (Melsungen, Germany)
Reddy's Laboratories Ltd. (Hyderabad, India)
LEO Pharma A/S (Ballerup, Denmark)
Aspen Holdings (Durban, South Africa)
Other Players
Heparin Market Analysis 2021:

Market Driver:

Rising Incidence ofChronic Disorders to Incite Business Development

The increasing prevalence of cardiovascular diseases around the world, including heart attacks and strokes will spur opportunities for the market. As per the American Heart Association (AHA) Heart Disease and Stroke Statistics, an estimated 5.3 million Americans suffered from atrial fibrillation in 2019. The growing demand for heparin among patients can have an excellent impact on the market. As per the Centers for Disease Control and Prevention, coronary heart disease is the most common type of heart disease, killing 365,914 people in 2017.4. About 18.2 million adults age 20 and older have CAD (about 6.7%). Moreover, 2 in 10 deaths from CAD happen in adults less than 65 years old. The increasing awareness about the benefits of heparin in the treatment and management of heart diseases will improve the prospects of the market in the foreseeable future.

Minimal Impact on the Market During COVID-19

The limitations on non-essential medical procedures and consultations has had a drastic impact on the global market amid COVID-19. The healthcare industry has observed a decline in other medical services besides coronavirus. The increased emphasis on COVID's vaccine has reduced the demand for other therapeutics. Furthermore, the lack of supply and production of heparin will simultaneously limit the scope of the market. However, government initiatives, including heavy investments and free medical aid will influence the healthy growth of the market in the time of the pandemic.

For more information visit : https://www.fortunebusinessinsights.com/heparin-market-104447

Regional Analysis:

High Adoption of Advanced Products to Boost Market in North America

The market size in North America stood at USD 4.28 billion in 2019. The growth in the region is attributed to the prevalence of cardiovascular diseases such as pulmonary embolism. The higher adoption of advanced heparin products will have an excellent effect on the market in the region. The increasing healthcare expenditure is expected to foster the healthy growth of the market in North America. The presence of major companies can further enhance the development of the market in the region. Europe is expected to hold the largest share owing to the acceptance of technologically advanced products in the region. The rising number of patients suffering from a range of cardiovascular diseases will further spur opportunities in the region. Asia Pacific is expected to experience a rapid growth rate owing to the growing patient population. The surging healthcare expenditure in the developing nations will have a tremendous effect on the market in Asia Pacific.

Key Development:

May 2019: Pfizer, Inc. announced that it has received the approval from the U.S. FDA for the administration of its heparin product offering, Fragmin to minimize the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients aged one month and above.

Key questions answered in the report:

What will the market growth rate of Heparin market in 2027?
What are the key factors driving the global Heparin market?
Who are the key manufacturers in Heparin market space?
What are the market opportunities, market risk and market overview of the Heparin market?
What are sales, revenue, and price analysis of top manufacturers of Heparin market?
Who are the distributors, traders and dealers of Heparin market?
What are the Heparin market opportunities and threats faced by the vendors in the global Heparin industry?
What are sales, revenue, and price analysis by types and applications of Heparin market?
What are sales, revenue, and price analysis by regions of Heparin industry?
Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/heparin-market-104447

Table of Content:

1 Heparin Market Overview

1.1 Heparin Product Overview

1.2 Heparin Market Segment by Type

1.3 Global Heparin Market Size by Type (2015-2027)

1.3.1 Global Heparin Market Size Overview by Type (2015-2027)

1.3.2 Global Heparin Historic Market Size Review by Type (2015-2021)

1.3.2.1 Global Heparin Sales Market Share Breakdown by Type (2015-2027)

1.3.2.2 Global Heparin Market Share Breakdown by Type (2015-2027)

1.3.2.3 Global Heparin Average Selling Price (ASP) by Type (2015-2027)

1.3.3 Global Heparin Market Size Forecast by Type (2021-2027)

1.3.3.1 Global Heparin Sales Market Share Breakdown by Application (2021-2027)

1.3.3.2 Global Heparin Revenue Market Share Breakdown by Application (2021-2027)

1.3.3.3 Global Heparin Average Selling Price (ASP) by Application (2021-2027)

1.4 Key Regions Market Size Segment by Type (2015-2021)

1.4.1 North America Heparin Sales Breakdown by Type (2015-2027)

1.4.2 Europe Heparin Sales Breakdown by Type (2015-2027)

1.4.3 Asia-Pacific Heparin Sales Breakdown by Type (2015-2027)

1.4.4 Latin America Heparin Sales Breakdown by Type (2015-2027)

1.4.5 Middle East and Africa Heparin Sales Breakdown by Type (2015-2027)

2 Global Heparin Market Competition by Company

2.1 Global Top Players by Heparin Sales (2015-2021)

2.2 Global Top Players by Heparin Revenue (2015-2021)

2.3 Global Top Players Heparin Average Selling Price (ASP) (2015-2021)

2.4 Global Top Company Heparin Manufacturing Base Distribution, Sales Area, Product Type

2.5 Heparin Market Competitive Situation and Trends

2.5.1 Heparin Market Growth Rate (2015-2021)

2.5.2 Global 5 and 10 Largest Company by Heparin Sales and Revenue in 2019

2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heparin as of 2019)

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245

This release was published on openPR.